|
eerste vaccinatie tegen 'severe acute respiratory syndrome'-coronavirus 2 met 'messenger'-ribonucleïnezuurvaccin (verrichting)
eerste vaccinatie tegen SARS-CoV-2 met mRNA-vaccin
eerste vaccinatie tegen 'severe acute respiratory syndrome'-coronavirus 2 met 'messenger'-ribonucleïnezuurvaccin
eerste toediening van mRNA-vaccin tegen COVID-19
eerste actieve immunisatie met SARS-CoV-2-mRNA-vaccin
Administration of first dose of SARS-CoV-2 mRNA vaccine
Administration of first dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid
First 2019 novel coronavirus mRNA immunization
First 2019-nCoV mRNA vaccination
First severe acute respiratory syndrome coronavirus 2 mRNA vaccination
First SARS-CoV-2 mRNA vaccination
First 2019-nCoV mRNA immunization
First 2019 novel coronavirus mRNA vaccination
First COVID-19 mRNA immunization
First SARS-CoV-2 mRNA immunization
First COVID-19 mRNA vaccination
Id1144997007
StatusPrimitive
Global Patient Set